Adherence to antipsychotics in schizophrenia
https://libcat.nshealth.ca/en/permalink/provcat33775
Emilio Sacchetti, Antonio Vita, Alberto Siracusano, Wolfgang Fleischhacker.
--Milan:
Springer
, c2014.
- Available Online
- View e-Book
- Location
- Online
Poor adherence to therapy is one of the main obstacles to treatment effectiveness in schizophrenia. It is the main determinant of relapse, hospitalization, symptom persistence, and poor psychosocial functioning and outcome. Adherence to treatment is affected by various factors related to the disease characteristics, to the patient him- or herself, to the treatment, and to the therapeutic relationship. Some of these factors are modifiable, and both pharmacological and non-pharmacological strateg…
- Available Online
- View e-Book
- Other Authors
- Sacchetti, Emilio
- Responsibility
- Emilio Sacchetti, Antonio Vita, Alberto Siracusano, Wolfgang Fleischhacker
- Place of Publication
- Milan
- Publisher
- Springer
- Date of Publication
- c2014
- Physical Description
- 1 online resource (xii, 159 pages)
- ISBN
- 9788847026797 (electronic bk.)
- 9788847026780
- Subjects (MeSH)
- Antipsychotic Agents - therapeutic use
- Medication Adherence
- Medication therapy management
- Patient Compliance
- Schizophrenia - drug therapy
- Subjects (LCSH)
- Schizophrenia - Treatment
- Abstract
- Poor adherence to therapy is one of the main obstacles to treatment effectiveness in schizophrenia. It is the main determinant of relapse, hospitalization, symptom persistence, and poor psychosocial functioning and outcome. Adherence to treatment is affected by various factors related to the disease characteristics, to the patient him- or herself, to the treatment, and to the therapeutic relationship. Some of these factors are modifiable, and both pharmacological and non-pharmacological strategies have been developed for this purpose.This book addresses the different aspects of adherence to treatment in schizophrenia and related disorders in a systematic but easy-to-use manual format. Chapters focus on a full range of issues, including pharmacological and non-pharmacological strategies to enhance adherence and continuity of care, relevant psychological factors, the importance of the patient-doctor relationship, and the need for an alliance with other care-givers.
- Contents
- Poor adherence to antipsychotic medication in people with schizophrenia: diffusion, consequences, and contributing factors -- Pharmacological strategies to enhance adherence in schizophrenia -- Non-pharmacological strategies to enhance adherence and continuity of care in schizophrenia -- Psychological issues in improving adherence and alliance.
- Format
- e-Book
- Location
- Online
CBT for schizophrenia : evidence-based interventions and future directions
https://libcat.nshealth.ca/en/permalink/provcat33211
edited by Craig Steel.
--Chichester, West Sussex, UK:
Wiley Blackwell
, c2013.
- Available Online
- View e-Book
- Location
- Online
Informed by the latest clinical research, this is the first book to assemble a range of evidence-based protocols for treating the varied presentations associated with schizophrenia through Cognitive Behavioural Therapy. This book: deals with a wide range of discrete presentations associated with schizophrenia, such as command hallucinations, violent behaviour or co-morbid post-traumatic stress disorder; covers work by the world's leading clinical researchers in this field; and includes illustr…
- Available Online
- View e-Book
- Other Authors
- Steel, Craig
- Responsibility
- edited by Craig Steel
- Alternate Title
- Cognitive behaviour therapy for schizophrenia
- Place of Publication
- Chichester, West Sussex, UK
- Publisher
- Wiley Blackwell
- Date of Publication
- c2013
- Physical Description
- 1 online resource, 274 p.
- ISBN
- 9781118330029 (electronic bk.)
- Subjects (MeSH)
- Cognitive Behavioral Therapy - methods
- Evidence-Based Medicine - methods
- Schizophrenia - therapy
- Subjects (LCSH)
- Schizophrenia - Treatment
- Cognitive therapy
- Abstract
- Informed by the latest clinical research, this is the first book to assemble a range of evidence-based protocols for treating the varied presentations associated with schizophrenia through Cognitive Behavioural Therapy. This book: deals with a wide range of discrete presentations associated with schizophrenia, such as command hallucinations, violent behaviour or co-morbid post-traumatic stress disorder; covers work by the world's leading clinical researchers in this field; and includes illustrative case material in each chapter.
- Format
- e-Book
- Location
- Online
Encyclopedia of schizophrenia : focus on management options
https://libcat.nshealth.ca/en/permalink/provcat33282
W. Wolfgang Fleischhacker and Ian P. Stolerman (eds.).
--London:
Springer
, c2011.
- Available Online
- View e-Book
- Location
- Online
This mini-encyclopedia aims to provide a survey of the wide range of interventions available for treating schizophrenia at a level appropriate for non-specialists who are beginning their engagement in the area and for others as a source of reference for the specialist. The pharmacological options are considered alongside psychosocial management approaches and the advantages and disadvantages of each treatment modality are outlined. The entries are written by leading experts, including basic and…
- Available Online
- View e-Book
- Other Authors
- Fleischhacker, W. W
- Stolerman, Ian P
- Responsibility
- W. Wolfgang Fleischhacker and Ian P. Stolerman (eds.)
- Place of Publication
- London
- Publisher
- Springer
- Date of Publication
- c2011
- Physical Description
- 1 online resource (x, 273 pages)
- ISBN
- 9781907673962 (electronic bk.)
- 9781907673177
- Subjects (MeSH)
- Schizophrenia - therapy
- Antipsychotic Agents
- Psychopharmacology
- Subjects (LCSH)
- Schizophrenia - Treatment
- Notes
- "This book consists of selections from the Encyclopedia of Psychopharmacology, 1st edition, edited by Prof. Ian Stolerman, published by Springer Verlag Berlin Heidelberg New York in 2010."
- Abstract
- This mini-encyclopedia aims to provide a survey of the wide range of interventions available for treating schizophrenia at a level appropriate for non-specialists who are beginning their engagement in the area and for others as a source of reference for the specialist. The pharmacological options are considered alongside psychosocial management approaches and the advantages and disadvantages of each treatment modality are outlined. The entries are written by leading experts, including basic and clinical scientists in academia and industry, and include descriptions of many relevant fundamental psychological and biological processes of the disorder. The volume owes much to the Encyclopedia of Psychopharmacology edited by Ian Stolerman IP (published by Springer-Verlag in 2010), from which some entries are reproduced. Where entries deal with pharmacological interventions, the aim is to provide detailed information on the neuropsychopharmacology of the substances from domains such as clinical, experimental, and molecular pharmacology, insofar as they impact upon understanding of schizophrenia. Articles on non-drug interventions review the most recent evidence base related to commonly applied psychotherapeutic and rehabilitative measures. Other essays focus upon the key concepts and research methods used in the field, describing the main features of investigative techniques and outlining their roles, the types of information obtained and why they are needed; the advantages and limitations of a technique may also be summarized. The essays are complemented by many short definitions of important terms; in the interest of ease of reading, these definitions are not assigned to named authors; they are typically related to specific essays that they cross-reference and relevant authorship details can be found in the latter.
- Contents
- Key Essays -- Active Avoidance / Marie-Louise G. Wadenberg -- Aggressive Behavior: Clinical Aspects / Emil F. Coccaro -- Aminergic Hypothesis for Schizophrenia / Hiroyuki Uchida and Shitij Kapur -- Animal Models for Psychiatric States / Paul Willner -- Antipsychotic Drugs / W. Wolfgang Fleischhacker -- Anti-Parkinson Drugs / Joseph H. Friedman -- Antipsychotic Medication: Future Prospects / Seiya Miyamoto -- Cognitive Behavioral Therapy for People with Schizophrenia / Gillian Haddock -- Cognitive Remediation in Schizophrenia Patients / Alice Medalia and Alice Saperstein -- Delayed Onset of Drug Effects / Stefan Leucht -- Delusional Disorder / Istvan Bitter -- Dissociative Anesthetics / Anthony Absalom and David Menon -- Family Based Approaches for Schizophrenia Patients / Andrea Fiorillo and Silvana Galderisi -- First-Generation Antipsychotics / Cyril Höschl -- Hallucinations / Eileen M. Joyce -- Hallucinogen / Abuse and Dependence / John H. Halpern, Pedro E. Huertas, Joji Suzuki, and Torsten Passie -- Neurotoxicity and Schizophrenia / Heleen B. M. Boos, H. D. Postma, and Wiepke Cahn -- Pediatric Schizophrenia / Christoph U. Correl -- Pharmacogenetics of Antipsychotic Drug Response in Schizophrenia / Eva J. Brandl and Daniel J. Müller -- Pharmacogenetics of Drug Side Effects and Safety / Anil K. Malhotra and Todd Lencz -- Postpsychotic Depressive Disorder of Schizophrenia / Samuel G. Siris -- Pre-psychotic States and Prodromal Symptoms / Patrick D. Mcgorry, Alison R. Yung -- Psychoeducation in the Management of Schizophrenia / Werner Kissing and Gabriele Pitschel-Walz -- Rating Scales and Diagnostic Schemata / David V. Sheehan and Kathy H. Sheehan -- Rehabilitation in Schizophrenia / Wulf Rössler and Andreas Marneros -- Schizophrenia / Alex Hofer -- Second and Third Generation Antipsychotics / Gary Remington.
- Format
- e-Book
- Location
- Online
Handbook of treatment-resistant schizophrenia
https://libcat.nshealth.ca/en/permalink/provcat33544
Leslie Citrome.
--London:
Springer Healthcare
, c2013.
- Available Online
- View e-Book
- Location
- Online
Handbook of Treatment-resistant Schizophrenia is a concise review of treatment-resistant schizophrenias definition, measurement tools, adherence issues, substance abuse, optimal dosing, clinicianpatient relationships, and current management approaches. The book was originally commissioned with the intention of creating a comprehensive text focusing on treatment-resistant schizophrenia and its management. The book explores many aspects of the background and practice- and research-based evidence …
- Available Online
- View e-Book
- Author
- Citrome, Leslie
- Responsibility
- Leslie Citrome
- Place of Publication
- London
- Publisher
- Springer Healthcare
- Date of Publication
- c2013
- Physical Description
- 1 online resource (x, 66 pages)
- ISBN
- 9781908517883 (electronic bk.)
- 9781908517869
- Subjects (LCSH)
- Schizophrenia - Treatment - Handbooks, manuals, etc
- Abstract
- Handbook of Treatment-resistant Schizophrenia is a concise review of treatment-resistant schizophrenias definition, measurement tools, adherence issues, substance abuse, optimal dosing, clinicianpatient relationships, and current management approaches. The book was originally commissioned with the intention of creating a comprehensive text focusing on treatment-resistant schizophrenia and its management. The book explores many aspects of the background and practice- and research-based evidence for treating this complex subset of schizophrenia, including psychopharmacological, somatic, and nonpharmacological treatment approaches. While exploring the various therapies for treatment-resistant schizophrenia, Dr Citrome also emphasizes the importance of building strong and trusting relationships between patients and their clinicians so the clinician can best manage their patients adherence and overall treatment.
- Contents
- Part One. Before categorizing someone as treatment-resistant -- Introduction -- A general treatment approach -- Adherence : the great masquerade of treatment-resistance -- Dosing of antipsychotics : what evidence do we use? -- Part Two. Management approaches -- Psychopharmacological approaches -- Somatic treatments -- Nonpharmacological approaches -- Conclusions.
- Format
- e-Book
- Location
- Online
Olanzapine (Zyprexa, Zyprexa Zydis)
https://libcat.nshealth.ca/en/permalink/chpams35690
Nova Scotia Health Authority. Pharmacy Services.
Halifax, NS:
Nova Scotia Health Authority
, 2022.
- Pamphlet Number
- 1669
- Available Online
- View Pamphlet
Olanzapine is most often used to treat psychosis or mania. This pamphlet explains how to take olanzapine, how it helps, how quickly it will work, how long you should take it, and possible side effects. A list of symptoms that need medical attention is included.
- Available Online
- View Pamphlet
- Corporate Author
- Nova Scotia Health Authority. Pharmacy Services
- Place of Publication
- Halifax, NS
- Publisher
- Nova Scotia Health Authority
- Date of Publication
- 2022
- Format
- Pamphlet
- Language
- English
- Physical Description
- 1 electronic document ([2] p.) : digital, PDF file
- Subjects (LCSH)
- Antipsychotic drugs
- Manic-depressive illness
- Schizophrenia--Treatment
- Specialty
- Medications
- Abstract
- Olanzapine is most often used to treat psychosis or mania. This pamphlet explains how to take olanzapine, how it helps, how quickly it will work, how long you should take it, and possible side effects. A list of symptoms that need medical attention is included.
- Responsibility
- Prepared by: Pharmacy Services
- Pamphlet Number
- 1669
Schizophrenia : recent advances in diagnosis and treatment
https://libcat.nshealth.ca/en/permalink/provcat33436
Phillip G. Janicak, Stephen R. Marder, Rajiv Tandon, Morris Goldman, editors.
--New York:
Springer
, c2014.
- Available Online
- View e-Book
- Location
- Online
Schizophrenia: Recent Advances in Diagnosis and Treatment is a major addition to the literature, offering practical, comprehensive coverage of diagnosis and treatment options, genetic issues, neuroimaging, long-term management of schizophrenia, and future directions and predictions of how clinical care of schizophrenia will change. The book is divided into five sections. Section 1 summarizes the present state of knowledge about the diagnosis and treatment of schizophrenia. This includes recent …
- Available Online
- View e-Book
- Other Authors
- Janicak, Philip G
- Marder, Stephen R
- Tandon, Rajiv
- Goldman, Morris
- Responsibility
- Phillip G. Janicak, Stephen R. Marder, Rajiv Tandon, Morris Goldman, editors
- Place of Publication
- New York
- Publisher
- Springer
- Date of Publication
- c2014
- Physical Description
- 1 online resource (xii, 331 pages)
- ISBN
- 9781493906567 (electronic bk.)
- 9781493906550
- Subjects (MeSH)
- Schizophrenia - diagnosis
- Schizophrenia - therapy
- Subjects (LCSH)
- Schizophrenia
- Schizophrenia - Diagnosis
- Schizophrenia - Treatment
- Abstract
- Schizophrenia: Recent Advances in Diagnosis and Treatment is a major addition to the literature, offering practical, comprehensive coverage of diagnosis and treatment options, genetic issues, neuroimaging, long-term management of schizophrenia, and future directions and predictions of how clinical care of schizophrenia will change. The book is divided into five sections. Section 1 summarizes the present state of knowledge about the diagnosis and treatment of schizophrenia. This includes recent changes in the DSM 5 categorization of schizophrenia and its implications for treatment. Section 2 considers recent discoveries into its pathoetiology, including the status of biological markers, genetics and neuroimaging as they relate to diagnosis and potential novel therapeutic approaches. Section 3 explores the optimization of present therapeutic approaches; novel treatments; and management of the substantial risks associated with both the illness and its present therapies. Section 4 discusses progress in the long-term management of schizophrenia, focusing on biological and psychotherapeutic strategies to improve functioning and facilitate recovery. Section 5 considers future directions and predictions of how diagnosis and treatment of schizophrenia will change. An invaluable addition to the field, Schizophrenia: Recent Advances in Diagnosis and Treatment is a definitive resource that will be of great interest to all clinicians caring for patients with schizophrenia.
- Contents
- Part I. Overview -- Introduction -- The Evolving Nosology of Schizophrenia: Relevance for Treatment -- Part II. Recent Research into the Pathophysiology of Schizophrenia -- Overview of Neurobiology -- Pathophysiology of Schizophrenia -- Genetics of Schizophrenia -- Recent Advances in Neuroimaging Biomarkers of Schizophrenia -- Part III. Medical Management of Schizophrenia -- Acute Management of Schizophrenia -- Therapeutic Neuromodulation for Treatment of Schizophrenia -- Pharmacogenetics in the Treatment of Schizophrenia -- Management of Comorbid Medical Conditions in Schizophrenia -- Management of Water Imbalance in Schizophrenia -- Management of Medication-Related Adverse Effects -- Part IV. Management of Schizophrenia and Its Long-Term Complications -- Long-Term Pharmacological Management of Schizophrenia -- Psychosocial Rehabilitation and Psychotherapy Approaches -- Part V. Future Directions and Implications -- Conclusion.
- Format
- e-Book
- Location
- Online
